Your browser doesn't support javascript.
loading
Evaluation of the sedative and some anticholinergic effects of the H1 antagonists loratadine and pheniramine in experimental animals
New Egyptian Journal of Medicine [The]. 1994; 10 (6): 2467-70
in English | IMEMR | ID: emr-34407
ABSTRACT
All antihistaminic drugs have adverse effect of some degree. The most common side effects are sedation and anticholinergic responses. On isolated rabbit jejunum pheniramine [1-2 ug/ml] reduced significantly contraction induced by a submaximal dose of acetylcholine. However, loratadine [1-16 ug/ml] produced no reduction. Loratadine in doses up to [300 mg/kg] which is more than 300 times the effective antihistaminic dose, produced no significant effect on spontaneous motor activity in motor coordination nor in parkinsonism induced by fluphenamine [10 mg/kg s.c] in adult rats. On the other hand, pheniraine [5 mg/kg] intraperitoneal reduced significantly spontaneous motor activity and motor coordination in experimental rats. Like loratadines, it has no effect on fluphenazine induced parkinsonism. It can be concluded that loratadine is a nonsedating antihistaminic with no peripheral or central anticholinergic effects even in doses 300 times the antihistaminic dose. So, it is a safe and well tolerate
Subject(s)
Search on Google
Index: IMEMR (Eastern Mediterranean) Main subject: Pheniramine / Loratadine / Histamine H1 Antagonists Limits: Animals Language: English Journal: New Egypt. J. Med. Year: 1994

Similar

MEDLINE

...
LILACS

LIS

Search on Google
Index: IMEMR (Eastern Mediterranean) Main subject: Pheniramine / Loratadine / Histamine H1 Antagonists Limits: Animals Language: English Journal: New Egypt. J. Med. Year: 1994